###begin article-title 0
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 33 38 <span type="species:ncbi:9606">Human</span>
###xml 84 89 <span type="species:ncbi:9606">Child</span>
###xml 106 109 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Regulation of CCR5 Expression in Human Placenta: Insights from a Study of Mother-to-Child Transmission of HIV in Malawi
###end article-title 0
###begin p 1
Conceived and designed the experiments: BRJ. Performed the experiments: BRJ. Analyzed the data: BRJ. Contributed reagents/materials/analysis tools: BRJ SRM. Wrote the paper: BRJ. Contributed to revisions of the paper: NF KEN SRM. Assisted with statistical methodology: NF KEN. Involved in the design and implementation of the original cohort study: VM. Supervised laboratory methodology: SRM.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 247 251 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 263 270 263 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 358 365 358 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 119 124 <span type="species:ncbi:9606">child</span>
###xml 141 144 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 146 149 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Human promoter polymorphisms in the chemokine co-receptor 5 gene (CCR5) have been noted for association with mother-to-child transmission of HIV (HIV MTCT) as well as reduced receptor expression in vitro, but have not been clearly associated with CCR5 expression in vivo. Placental expression of CCR5 may be influenced by such polymorphisms as well as other in vivo regulatory factors.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 326 330 326 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 492 496 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 525 529 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 652 660 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 700 708 691 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 856 860 844 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 996 1000 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 38 44 <span type="species:ncbi:9606">infant</span>
###xml 143 149 <span type="species:ncbi:9606">infant</span>
###xml 751 754 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 809 812 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 917 920 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We evaluated the associations between infant CCR5 polymorphisms, measures of maternal infection, and placental expression of CCR5 among mother-infant pairs in Blantyre, Malawi. RNA was extracted from placental tissue and used in multiplex real-time PCR to quantify gene expression. Through linear regression, we observed that CCR5-2554T (beta = -0.67, 95% CI = -1.23, -0.11) and -2132T (beta = -0.75, 95% CI = -0.131, -0.18) were significantly associated with reduced placental expression of CCR5. An incremental increase in CCR5 expression was observed for incremental increases in expression of two heparan sulfate genes involved in viral infection, HS3ST3A1 (beta = 0.27, 95% CI = 0.18, 0.35) and HS3ST3B1 (beta = 0.11, 95% CI = 0.06, 0.18). Among HIV infected mothers, an incremental increase in maternal HIV viral load was also associated with higher CCR5 expression (beta = 0.76, 95% CI = 0.12, 1.39). Maternal HIV status had no overall effect (beta = 0.072, 95% CI = -0.57, -0.72). Higher CCR5 expression was observed for mothers with malaria but was not statistically significant (beta = 0.37, 95% CI = -0.43, 1.18).
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 279 284 <span type="species:ncbi:9606">child</span>
###xml 301 304 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
These results provide in vivo evidence for genetic and environmental factors involved in the regulation of CCR5 expression in the placenta. Our findings also suggest that the measurement of placental expression of CCR5 alone is not an adequate indicator of the risk of mother-to-child transmission of HIV.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 211 214 211 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-UNAIDS1">[1]</xref>
###xml 47 52 <span type="species:ncbi:9606">women</span>
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 105 113 <span type="species:ncbi:9606">children</span>
###xml 138 141 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 181 186 <span type="species:ncbi:9606">child</span>
###xml 201 204 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 216 219 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
In sub-Saharan Africa, over 1,300,000 pregnant women were living with HIV in 2007, and more than 300,000 children are newly infected with HIV each year, primarily through mother-to-child transmission (HIV MTCT) [1]. HIV MTCT can occur during pregnancy (intrauterine transmission), during labor and delivery (intrapartum transmission), or through breastfeeding (postpartum transmission).
###end p 9
###begin p 10
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Dragic1">[2]</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 184 187 184 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Samson1">[3]</xref>
###xml 344 347 344 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Burns1">[4]</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Fernandez1">[5]</xref>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 576 579 572 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Dragic1">[2]</xref>
###xml 581 584 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Dean1">[6]</xref>
###xml 586 589 582 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Deng1">[7]</xref>
###xml 591 594 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Doranz1">[8]</xref>
###xml 596 599 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Zimmerman1">[9]</xref>
###xml 601 605 597 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Clegg1">[10]</xref>
###xml 607 611 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Knudsen1">[11]</xref>
###xml 613 617 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Kostrikis1">[12]</xref>
###xml 619 623 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-McDermott1">[13]</xref>
###xml 706 710 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Benkirane1">[14]</xref>
###xml 712 716 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Hladik1">[15]</xref>
###xml 718 722 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Salkowitz1">[16]</xref>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 219 222 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 514 519 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The chemokine (CC motif) receptor 5 (CCR5), a co-receptor of the CD4 receptor, is used by macrophage-tropic (R5) HIV-1 for cell entry [2] and is genetically regulated by the CCR5 gene [3]. It has been demonstrated that HIV infection and progression is inhibited by competitive ligands (i.e. the chemokine RANTES) binding with the CCR5 receptor [4], [5]. Genetic variants of the CCR5 gene such as the 32-basepair deletion in the open reading frame (CCR5 Delta32) and promoter polymorphisms are also associated with human susceptibility to infection and/or progression of HIV-1 [2], [6], [7], [8], [9], [10], [11], [12], [13]. This is likely explained by variable receptor expression resulting from mutation [14], [15], [16].
###end p 10
###begin p 11
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Behbahani1">[17]</xref>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 159 163 159 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 294 301 294 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 76 79 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 371 377 <span type="species:ncbi:9606">infant</span>
###xml 416 419 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 440 443 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 529 535 <span type="species:ncbi:9606">infant</span>
Upregulation of CCR5 in the placenta has been noted to increase the risk of HIV MTCT [17]. However, CCR5 expression may be altered not only by variants in the CCR5 gene but also by environmental factors such as maternal infection. Variability in such factors may limit the external validity of in vivo findings. Thus, one aim of this study was to evaluate the affects of infant CCR5 promoter polymorphisms, maternal HIV infection, maternal HIV viral load, and maternal malaria, on CCR5 expression in placental tissue from mother-infant pairs in Malawi.
###end p 11
###begin p 12
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Bobardt1">[18]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Argyris1">[19]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Gallagher1">[20]</xref>
###xml 919 920 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 951 952 951 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1034 1035 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1058 1066 1058 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 1076 1084 1076 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 1093 1094 1093 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 1212 1220 1212 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1220 1224 1220 1224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Geraghty1">[21]</xref>
###xml 1226 1230 1226 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Shukla1">[22]</xref>
###xml 1232 1236 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Warner1">[23]</xref>
###xml 158 163 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1195 1200 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 1282 1287 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In cells lacking the CD4 receptor, such as brain microvascular endothelial cells (BMECs), or primary genital epithelial cells (PGECs), alternative routes for HIV-1 attachment and cell entry have been suggested, including the use of heparan sulfate proteoglycans (HSPGs) [18], [19]. HSPGs are one type of proteoglycan, which is composed of a core protein (i.e. syndecan) and one or more covalently attached glycosaminoglycan (GAG) chains. HSPGs are proteoglycans with heparan sulfate (HS) attached, a highly sulfated polysaccharide made up of glucosamine and glucuronic/iduronic acid repeating disaccharide units [20]. The binding properties and thereby function of HSPGs are determined by the structure and sequence of the disaccharide units, consequential of HS biosynthesis. Various HS subtypes are produced through HS biosynthesis, which involves genetically regulated biosynthetic enzymes. One example subtype is 3-O-sulfated HS, synthesized by 3-O-sulfotransferase, which is encoded by the genes, heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1 (HS3ST3A1) and B1 (HS3ST3A1). The 3-O-sulfated HS subtype has been shown to play a key role in susceptibility to herpes simplex virus -1 (HSV-1) infection in vitro[21], [22], [23] but has not been evaluated in the context of HIV-1 infection.
###end p 12
###begin p 13
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Cladera1">[24]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Gatignol1">[25]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Mondor1">[26]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Saphire1">[27]</xref>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Ugolini1">[28]</xref>
###xml 666 670 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Slimani1">[29]</xref>
###xml 672 676 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Slimani2">[30]</xref>
###xml 678 682 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Tkachenko1">[31]</xref>
###xml 744 748 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Middleton1">[32]</xref>
###xml 750 754 745 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Witt1">[33]</xref>
###xml 864 868 859 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Wagner1">[34]</xref>
###xml 999 1003 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Hoogewerf1">[35]</xref>
###xml 1237 1241 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Murooka1">[36]</xref>
###xml 1332 1336 1327 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Hoogewerf1">[35]</xref>
###xml 1338 1342 1333 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Martin1">[37]</xref>
###xml 1387 1391 1382 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Maione1">[38]</xref>
###xml 94 99 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 255 260 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 379 382 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Although not specific to HS subtype, it is known that HSPGs can facilitate internalization of HIV-1 transactivator protein, Tat [24], which can induce cytokine activity and bind to heparan [25]. Treatment of cells bearing HSPGs with heparinase diminishes HIV-1 attachment and infectivity for CD4+ HeLa cells and macrophages [26], [27], an effect that was shown to differ between HIV viruses using CCR5 as a coreceptor compared to the CXCR4 coreceptor [28]. Furthermore, chemokines such as RANTES, MIP-1alpha, and MIP-1ss, bind not only with the CCR5 coreceptor but also with glycossaminoglycans (GAGs) bearing heparin, heparan sulfate, or chondroitin sulfate A or C [29], [30], [31]. GAGs can also strongly influence the activity of chemokines [32], [33]. Specifically, chemokines can be stored and released from T lymphocytes cytolotic granules complexed to GAGs [34], and binding with GAGs can influence chemokine structure and lead to aggregation, possibly protecting chemokines from degradation [35]. One study demonstrated that CCL5 (RANTES)-CCR5 binding-mediated apoptosis was dependent on cell-surface GAG binding and that the addition of exogenous heparin or chondroitin sulfate plus GAG digestion protected cells from apoptosis [36]. More recent studies have suggested that GAGs facilitate chemokine binding with receptors [35], [37], perhaps through electrostatic interactions [38].
###end p 13
###begin p 14
###xml 301 305 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Razi1">[39]</xref>
###xml 422 430 422 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 435 443 435 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 50 53 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 599 602 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
It is likely that both CCR5 and HS play a role in HIV MTCT, possibly through interactions within placental tissue. Because CCR5 and HS are genetically regulated, evaluation of pertinent gene expression may provide clues for what takes place at the protein level. Thus, in addition to an evaluation of CCR5 expression in the placenta, we quantified the expression of two key HS genes highly expressed in the placenta [39]: HS3ST3A1 and HS3ST3B1, responsible for the synthesis of 3-O-sulfated HS. HS gene expression was evaluated for association with CCR5 expression as well as with susceptibility to HIV MTCT in Malawi. The overall aim of this work was to describe how genetic and environmental factors may regulate CCR5 expression in the placenta.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Ethics Statement
###end title 16
###begin p 17
###xml 228 240 <span type="species:ncbi:9606">participants</span>
This research was approved by the University of North Carolina Institutional Review Board and the University of Malawi College of Medicine Research Ethics Committee (COMREC). Written informed consent was obtained from all study participants at the time of recruitment. Consent forms were in both English and Chichewa languages.
###end p 17
###begin title 18
Study Population
###end title 18
###begin p 19
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Mwapasa1">[40]</xref>
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Mwapasa2">[41]</xref>
###xml 4 16 <span type="species:ncbi:9606">participants</span>
###xml 71 74 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 215 227 <span type="species:ncbi:9606">participants</span>
###xml 332 335 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 361 364 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 458 461 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 542 548 <span type="species:ncbi:9606">infant</span>
The participants were a subset of a larger cohort study of malaria and HIV in pregnancy (MHP), previously described [40], [41]. Fresh placental tissue samples from the MHP cohort were obtained from consenting study participants at delivery and immediately frozen at -80 degrees Celsius (degreesC). Placental tissue samples from 723 HIV positive mothers and 419 HIV negative mothers were transported to the University of North Carolina at Chapel Hill. Of the HIV positive mothers, a total of 411 samples had data on transmission status of the infant.
###end p 19
###begin p 20
###xml 438 439 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 52 55 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 81 87 <span type="species:ncbi:9606">infant</span>
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 121 127 <span type="species:ncbi:9606">infant</span>
###xml 146 149 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 199 205 <span type="species:ncbi:9606">infant</span>
###xml 210 213 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 262 268 <span type="species:ncbi:9606">infant</span>
###xml 277 280 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 328 334 <span type="species:ncbi:9606">infant</span>
###xml 650 656 <span type="species:ncbi:9606">infant</span>
There were five transmission groups of interest: 1) HIV negative mother/negative infant, 2) HIV positive mother/negative infant at all visits, 3) HIV positive mother/intrauterine transmission to the infant, 4) HIV positive mother/intrapartum transmission to the infant, and 5) HIV positive mother/postpartum transmission to the infant. Power analyses indicated that a sample size of 200 would provide 80% power to detect a difference in r2 of 0.03 across groups. To obtain a slightly larger sample size of 250, a sample of 50 individuals was randomly selected from each of the five transmission categories, where possible. Only 47, 49, and 17 mother-infant pairs were available for intrauterine, intrapartum, or postpartum transmission events, respectively, giving a total sample size of N = 213.
###end p 20
###begin title 21
Gene Expression and Genotyping
###end title 21
###begin p 22
###xml 294 301 294 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Kim1">[42]</xref>
###xml 430 434 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Kim1">[42]</xref>
###xml 895 900 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 919 937 883 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1, HS3ST3B1</italic>
###xml 942 946 906 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1153 1158 1101 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1217 1221 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 1230 1234 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1391 1395 1339 1343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Bruse1">[43]</xref>
###xml 1397 1401 1345 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 1416 1420 1364 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1480 1484 1428 1432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 2200 2204 2137 2141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Bruse1">[43]</xref>
###xml 2206 2210 2143 2147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 65 71 <span type="species:ncbi:9606">infant</span>
###xml 1196 1202 <span type="species:ncbi:9606">Infant</span>
RNA was extracted from frozen placental tissue of the 213 mother-infant pairs using RNeasy mini kit (Qiagen, Valencia, CA). In order to quantify gene expression for each RNA sample, multiplex real-time PCR was run on 96-well plates using ABI 7700 Sequence Detector (PE Biosystems) according to methods previously described [42]. A total volume of 30 microl was used, which included 10 microl of RNA and 20 microl reaction mixture [42]. The cycle conditions were 30 min at 48degreesC for the RT reaction, 10 min at 94degreesC, and then 40 temperature cycles (15 sec at 94degreesC and 1 min at 60degreesC). Relative quantification was performed where each 96-well plate was normalized to an endogenous placental RNA control sample. Negative control samples (water) were used to assess the presence of genomic DNA contamination. The difference in cycle threshold (Ct) value between a control gene, GAPDH, and target gene (HS3ST3A1, HS3ST3B1, or CCR5) was obtained for each sample (DeltaCt). That value was subtracted from the DeltaCt value of the endogenous control sample (DeltaDeltaCt) and then transformed to a percent change in gene expression between GAPDH and the target gene for each sample. Infant genotyping of CCR2-64I and CCR5 promoter polymorphisms were determined using a multiplex ligase detection reaction (LDR) based method with flow cytometric technology, previously described [43], [44]. Briefly, the CCR5 promoter region containing the seven promoter SNPs and the CCR2 open reading frame were PCR-amplified. The amplicon was probed with an upstream allele specific primer with a unique 24 nucleotide FlexMAPtrade markTAG sequence extension (Luminex(R) Corporation, Austin, TX) and a downstream 5' phosphorylated/3' biotinylated conserved sequence primer. After allele specific hybridization, the primers were ligated, ligation products were hybridized with fluorescent bead-labeled anti-TAG probes, and the 3' biotin group was labeled with phycoerythrin (PE). To determine genotypes, the mean fluorescence intensity of the allele-specific LDR:bead-labeled anti-TAG hybrid complexes was read on a BioPlex array reader (Bio-Rad Laboratories, Hercules, CA) into allele specific channels [43], [44].
###end p 22
###begin title 23
Statistical Analysis
###end title 23
###begin p 24
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 161 169 161 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s001">Table S1</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Mummidi1">[45]</xref>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 872 880 872 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s002">Table S2</xref>
###xml 105 111 <span type="species:ncbi:9606">Infant</span>
The percent change in CCR5 expression was log-transformed in order to approximate a normal distribution. Infant CCR2/CCR5 SNPs were categorized into haplotypes (Table S1), based on phylogeny as previously described [45]. In order to evaluate the association between SNP/haplotype and CCR5 expression in the placenta, linear regression was performed using log-transformed CCR5 expression as the continuous outcome. Logistic regression was also employed to evaluate the association between SNP/haplotype and high vs. low CCR5 expression, dichotomized at the median value. Due to small cell sizes for some polymorphisms, SNPs and haplotypes were categorized as carriers of the variant/haplotype compared to non-carriers and analyzed according to a dominant genetic model. Because the SNPs were not completely independent, exhibiting variable pairwise linkage disequilibrium (Table S2), Bonferroni correction was not employed to adjust for multiple comparisons.
###end p 24
###begin p 25
###xml 22 30 22 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 282 285 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 296 299 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The percent change in HS3ST3A1 expression and HS3ST3B1 expression were also log-transformed and individually evaluated for association with CCR5 expression through linear regression, using CCR5 expression as the continuous outcome. Measures of maternal infection including maternal HIV, maternal HIV viral load (MVL), and maternal malaria were uniquely evaluated for association with CCR5 expression, also through linear regression.
###end p 25
###begin p 26
###xml 28 42 28 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5, HS3ST3A1</italic>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 95 98 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 133 136 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Finally, gene expression of CCR5, HS3ST3A1, and HS3ST3B1 was investigated for association with HIV MTCT through logistic regression. HIV MTCT was coded as 1 (transmission occurred) vs. 0 (no transmission). Different transmission time points (IU, IP, and PP) were evaluated in independent logistic regression models. Because gene expression did not meet the assumption of linearity of the logit, it was categorized into tertiles for this model.
###end p 26
###begin p 27
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Rothman1">[46]</xref>
###xml 49 52 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 155 158 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Because MVL is known to be a strong predictor of HIV MTCT, it was evaluated for effect measure modification of the association between gene expression and HIV MTCT by calculating the Mantel-Haenszel test of homogeneity of the odds ratio (OR) across MVL quartiles. It was also evaluated for confounding by using the percent change in estimate criterion: |ln(CoRR)|*100>10%, where |ln(CoRR)| = |ln(crude OR-adjusted OR)|*100 [46].
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Study Population
###end title 29
###begin p 30
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Bruse1">[43]</xref>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 22 28 <span type="species:ncbi:9606">infant</span>
###xml 147 150 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 192 199 <span type="species:ncbi:9606">infants</span>
###xml 211 214 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 273 276 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 286 293 <span type="species:ncbi:9606">infants</span>
###xml 395 401 <span type="species:ncbi:9606">infant</span>
###xml 432 435 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 445 452 <span type="species:ncbi:9606">infants</span>
###xml 456 459 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 487 490 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 500 507 <span type="species:ncbi:9606">infants</span>
###xml 511 514 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 546 549 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 559 566 <span type="species:ncbi:9606">infants</span>
###xml 570 573 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 614 620 <span type="species:ncbi:9606">infant</span>
###xml 644 647 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A total of 212 mother-infant pairs evaluated for gene expression had previously been genotyped for CCR2/CCR5 polymorphisms [43]. This included 154 HIV positive mothers, 103 (67%) of which had infants who became HIV positive by 12 weeks postpartum and 51 (33%) of which had HIV negative infants. Following quality control, CCR5 SNP genotypes and placental expression was available for 196 mother-infant pairs. This included 44 (22%) HIV negative infants of HIV positive mothers, 98 (50%) HIV positive infants of HIV positive mothers, and 54 (28%) HIV negative infants of HIV negative mothers. A total of 160 mother-infant pairs also had data on HIV maternal viral load.
###end p 30
###begin title 31
CCR5 Gene Expression and CCR5 Variants
###end title 31
###begin p 32
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 175 183 175 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 358 366 358 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 368 376 368 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 382 386 382 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 496 500 494 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 502 509 500 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 584 588 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 713 717 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 798 802 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1023 1030 1019 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 1064 1068 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1119 1123 1115 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 1252 1259 1248 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 1188 1191 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The overall mean and standard deviation (SD) of the cycle threshold values were 26.99 (SD = 4.00), 27.93 (SD = 3.92), 24.56 (2.27), and 24.51 (SD = 3.50) for GAPDH, HS3ST3A1, HS3ST3B1, and CCR5, respectively. The mean and SD of the log %change in gene expression relative to GAPDH expression was 5.83 (SD = 1.39), 4.63 (SD = 0.83), and 5.74 (SD = 2.02), for HS3ST3A1, HS3ST3B1, and CCR5, respectively. The CCR5-2132C-->T variant was significantly associated with variable placental expression of CCR5 (Table 1), where carriers of the T variant displayed lower placental expression of CCR5 (mean log %change = 5.53, range = -1.61, 9.40) compared to non carriers (mean log %change = 5.87, range = 1.95, 14.55). The CCR5-2554 G-->T variant was also significantly associated with a lower expression of CCR5 (mean log %change for T allele = 5.69, range = -1.61, 9.91; mean log %change for G allele = 5.77, range = 1.95, 14.55), although this finding was not statistically significant in the analysis of high vs. low expression (Table 1). The minor allele frequency for CCR5-2132T and -2554T was 0.23 and 0.29, respectively. CCR5 SNPs -2459G, -2135T, and -1835T corresponded to a lower risk of HIV MTCT, but these results were not statistically significant (Table 1).
###end p 32
###begin title 33
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
Frequencies and mean CCR5 expression by CCR5 SNP/haplotype category.
###end title 33
###begin p 34
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 200 201 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 203 204 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Linear regression for the association between CCR5 expression and CCR5 SNP/haplotype: Continuous outcome of placental expression. beta: Beta coefficient, 95% CI: 95% Confidence Interval for the Beta, p: p-value.
###end p 34
###begin p 35
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
Logistic regression for the association between CCR5 expression and CCR5 SNP/haplotype: Dichotomous outcome of high vs. low placental expression of CCR5 dichotomized at the median value. OR: Odds Ratio, 95% CI: 95% Confidence Interval for the Odds Ratio.
###end p 35
###begin p 36
pound # Copies: Number of copies of haplotype: 0, 1, or 2 copies possible per subject. SNPs and haplotypes categorized as having one or more copies of the variant allele or haplotype compared to zero copies.
###end p 36
###begin title 37
Linear regression for the associations between gene expression variables.
###end title 37
###begin p 38
###xml 149 150 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 152 153 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Continuous placental gene expression variables compared via linear regression; beta: Beta coefficient; 95% CI: 95% Confidence Interval for the Beta; p: p-value.
###end p 38
###begin p 39
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 75 83 75 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s001">Table S1</xref>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 149 156 149 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 282 289 282 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 307 311 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 411 415 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t001">Table 1</xref>
###xml 36 42 <span type="species:ncbi:9606">infant</span>
The A haplotype, which contains the infant alleles CCR5 -2132C and -2554G (Table S1), was associated with higher expression of CCR5 in the placenta (Table 1). A statistically significant association in the opposite direction (lower expression of CCR5) was observed for haplotype D (Table 1), which contains CCR5 -2132T and -2554T. All other alleles were the same across haplotypes A and D. Associations between CCR5 expression and other haplotypes were not statistically significant (Table 1).
###end p 39
###begin title 40
Gene Expression Interplay in the Placenta
###end title 40
###begin p 41
###xml 57 65 57 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 165 173 165 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0009212-g001">Figure 1</xref>
###xml 327 335 327 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 339 347 339 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 398 405 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t002">Table 2</xref>
An interesting interplay between placental expression of HS3ST3A1, HS3ST3B1, and CCR5 was observed in this study. An incremental increase in placental expression of HS3ST3A1 or HS3ST3B1 corresponded to an incremental increase in placental expression of CCR5 (Figure 1). The positive association between placental expression of HS3ST3A1 or HS3ST3B1and CCR5 expression was statistically significant (Table 2).
###end p 41
###begin title 42
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
Pattern of association between placental expression of heparan sulfate genes and CCR5.
###end title 42
###begin p 43
Scatter Plots (left) and Predicted Linear Plots (right).
###end p 43
###begin title 44
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Association between CCR5 placental expression and the risk of HIV MTCT at different time points.
###end title 44
###begin p 45
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 72 75 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Logistic regression for association between CCR5 expression tertile and HIV MTCT (transmission vs. no transmission); OR: Odds Ratio; 95% CI: 95% Confidence Interval for the Odds Ratio; p: p-value.
###end p 45
###begin title 46
CCR5 Expression and Measures of Maternal Infection
###end title 46
###begin p 47
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 117 118 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 223 227 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 327 331 324 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 378 379 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 479 483 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 575 576 566 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 157 160 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 188 191 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Maternal HIV infection was not associated with CCR5 expression in the placenta (beta = 0.072, 95% CI = -0.57, -0.72, p = 0.826, N = 194). However, among the HIV infected mothers, maternal HIV viral load was associated with CCR5 expression, where an incremental increase in viral load corresponded to an incremental increase in CCR5 expression (beta = 0.76, 95% CI = 0.12, 1.39; p = 0.020, N = 92). Maternal malaria infection also corresponded to a higher placental expression of CCR5, but the association was not statistically significant (beta = 0.37, 95% CI = -0.43, 1.18, p = 0.362, N = 170).
###end p 47
###begin title 48
###xml 28 31 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Gene Expression and Risk of HIV MTCT
###end title 48
###begin p 49
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 359 363 359 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 392 393 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 704 708 701 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 855 859 852 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 880 887 877 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0009212-t003">Table 3</xref>
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 322 325 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 955 958 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
A general trend of increasing risk of HIV MTCT with increasing expression of CCR5 was observed but these findings were not statistically significant (Medium vs. low tertile OR = 1.16, 95% CI = 0.49, 2.73; High vs. low tertile OR = 1.26, 95% CI = 0.52, 3.03). Log maternal viral load did not modify the association between HIV MTCT and placental expression of CCR5 (Mantel-Haenszel OR = 0.22, p = 0.683). In addition, MVL was not a confounder in the association based on a less than 10% change in the effect estimates after adjustment for MVL (%ln(CoRR) = 6.7%) and because MVL was not associated with CCR5 expression (beta = 0.02, 95% CI = -0.35, 0.39). Although the estimates of the association between CCR5 expression and each transmission time point were not very precise, a similar increased risk of transmission was observed for higher expression of CCR5 at all time points (Table 3). No significant association between the heparan sulfate genes and HIV MTCT was observed (data not shown).
###end p 49
###begin title 50
###xml 18 21 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5 Variants and HIV MTCT
###end title 50
###begin p 51
###xml 32 36 32 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 355 359 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 460 468 460 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s003">Table S3</xref>
###xml 175 178 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 254 257 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The findings of Pedersen et al. [44] were replicated in this subset of the original cohort from Malawi, with regards to the direction of association between each CCR5 SNP and HIV MTCT. One exception was the association between CCR5-1835T and the risk of HIV MTCT, which varied slightly in direction compared to previous findings (OR = 1.06 vs. RR = 0.84) [44]. Some findings also had variable statistical significance which may be a reflection of sample size (Table S3).
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 383 387 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 513 521 513 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s001">Table S1</xref>
###xml 523 527 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 552 559 552 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 573 577 573 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 593 597 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 636 640 632 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 132 135 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 142 148 <span type="species:ncbi:9606">Infant</span>
###xml 269 275 <span type="species:ncbi:9606">infant</span>
###xml 323 329 <span type="species:ncbi:9606">Infant</span>
###xml 432 438 <span type="species:ncbi:9606">infant</span>
This study evaluated the regulation of CCR5 expression in the placenta by genetic and environmental factors involved in the risk of HIV MTCT. Infant CCR5 promoter polymorphisms -2132T and -2554T were associated with lower expression of CCR5 in the placenta, as was the infant haplotype D, which is tagged by these alleles. Infant haplotype A was associated with significantly higher CCR5 expression in the placenta and differs from infant haplotype D in that it contains the wild type alleles, -2132C and -2554G (Table S1) [44]. These findings provide in vivo evidence for CCR5-2554 G-->T and CCR5 -2132C-->T related down regulation of CCR5 expression in the placenta.
###end p 53
###begin p 54
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Pedersen1">[44]</xref>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 570 578 570 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s003">Table S3</xref>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 658 662 658 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 879 883 879 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 926 934 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s003">Table S3</xref>
###xml 1050 1058 1050 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0009212.s003">Table S3</xref>
###xml 1478 1482 1478 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 102 105 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 203 206 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 250 256 <span type="species:ncbi:9606">infant</span>
###xml 276 279 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 484 487 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 678 681 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 916 919 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1164 1170 <span type="species:ncbi:9606">infant</span>
###xml 1223 1229 <span type="species:ncbi:9606">infant</span>
###xml 1333 1339 <span type="species:ncbi:9606">infant</span>
###xml 1541 1544 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We expected the SNPs associated with lower CCR5 expression to also be associated with a lower risk of HIV MTCT, and for SNPs associated with higher CCR5 expression to be associated with a higher risk of HIV MTCT. Referring to the association between infant CCR2/CCR5 SNPs and HIV MTCT previously described [44] and based on our replicate analyses, we found that this was not always the case. Notably, CCR5 -2733G was associated with higher CCR5 expression compared to a lower risk of HIV MTCT, although the association with expression was not statistically significant (Table S3). CCR5 SNPs -2554T, -2132T, and -2086G also showed discrepant associations for CCR5 expression and HIV MTCT, with variable statistical significance. The only discrepant finding that was statistically significant for both associations was observed for the D haplotype, which was associated with lower CCR5 expression but a higher risk of HIV MTCT (Table S3). Haplotype D varies from all other haplotypes with regards to the -2132T allele, which displayed similar results (Table S3). It is possible that these discrepancies reflect smaller sample sizes or the fact that we are comparing infant genotypes/haplotypes with a combined measurement of infant and maternal placental gene expression. More expensive techniques were required to separate mother and infant tissue and we were unable to pursue this in our study. Despite this limitation, the SNP/haplotype associations suggest that predictors of CCR5 expression do not directly correlate to the prediction of HIV MTCT and that these outcomes should be considered independently.
###end p 54
###begin p 55
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0009212-Behbahani1">[17]</xref>
###xml 755 759 755 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 163 166 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 287 293 <span type="species:ncbi:9606">infant</span>
###xml 813 816 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 943 946 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The discrepant SNP/haplotype associations with CCR5 expression and HIV MTCT were partnered with the finding that CCR5 placental expression was not associated with HIV MTCT. To obtain the best power, this association was first evaluated by using the cumulative transmission status of the infant (occurring at birth, 6 weeks, or 12 weeks postpartum), and showed no significant association. Because placenta samples were obtained at delivery, the measured CCR5 expression was viewed to be most representative of the expression occurring during labor and delivery and thus, most relevant to the risk of IP transmission. For both cumulative and IP transmission, although the direction of effect was consistent with previous findings [17], where an increase in CCR5 expression contributed to an increase in the risk of HIV MTCT, the association was not statistically significant. It is likely that other factors played a stronger role in predicting HIV MTCT in this study population.
###end p 55
###begin p 56
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 94 97 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 132 135 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 237 240 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 335 338 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Disease severity appeared to be an important regulator of placental expression of CCR5. Among HIV infected mothers, higher maternal HIV viral load was significantly associated with higher CCR5 placental expression. Thus, the presence of HIV infection alone may not make as great of an impact on CCR5 expression as does the severity of HIV disease or viral burden experienced by the individual.
###end p 56
###begin p 57
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 200 204 200 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 134 137 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 512 515 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 587 590 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 683 686 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Unlike maternal HIV viral load, maternal malaria was not a significant predictor of CCR5 expression. We limited this analysis to only HIV positive mothers and found that maternal malaria did increase CCR5 expression in the placenta but that it was not statistically significant (data not shown). Thus, we could not make any broad conclusions from the analyses with malaria. Furthermore, MVL and maternal malaria did not confound or act as effect measure modifiers in the associations between CCR5 expression and HIV MTCT, suggesting that accounting for a key co-infection or severity of HIV infection did not explain the lack of a significant association between CCR5 expression and HIV MTCT.
###end p 57
###begin p 58
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 288 289 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3A1</italic>
###xml 329 337 329 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HS3ST3B1</italic>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 496 500 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 904 908 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 997 1002 <span type="species:ncbi:9606">human</span>
One of the most important findings from this study was the revelation of a possible interaction between CCR5 and heparan sulfate at the genetic level. Up-regulation of CCR5 expression in the placenta was observed at higher expression levels of two genes involved in the biosynthesis of 3-O-sulfated heparan sulfate, HS3ST3A1 and HS3ST3B1. These findings were statistically significant and to our knowledge, are novel in vivo findings. It is possible that each heparan sulfate gene interacts with CCR5 in the placenta, causing up-regulation, or that the genes share transcription regulatory regions or factors. As previously noted, heparan sulfate has been shown to interact with chemokines which bind to CCR5, such as RANTES, but has not been evaluated for any interaction with CCR5 or related factors at the genetic level. Our findings press the importance of additional research on heparan sulfate and CCR5-related factors that may individually or cooperatively contribute to viral infection in human populations.
###end p 58
###begin p 59
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 62 65 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 404 407 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Overall, this study demonstrated the complexity of predicting HIV MTCT in human populations and offers new insights into regulatory factors of CCR5 expression in the placenta. Additional epidemiological investigations are warranted in order to more clearly elucidate how CCR5 and heparan sulfate genes may interact in vivo and whether combined genetic and environmental factors contribute to the risk of HIV MTCT in other populations.
###end p 59
###begin title 60
Supporting Information
###end title 60
###begin p 61
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
CCR2/CCR5 haplotypes.
###end p 61
###begin p 62
(0.04 MB DOC)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin p 64
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR2</italic>
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
Pairwise linkage disequilibrium for CCR2-64I and CCR5 promoter polymorphisms.
###end p 64
###begin p 65
(0.04 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 92 95 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5 SNP associations with CCR5 placental expression compared to CCR5 SNP associations with HIV MTCT.
###end p 67
###begin p 68
(0.06 MB DOC)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
We wish to thank Dr. Hyungsuk Kim for the gene expression work conducted at the Animal Clinical Chemistry and Gene Expression Laboratories, University of North Carolina at Chapel Hill, and Dr. Jian Liu from the University of North Carolina at Chapel Hill School of Pharmacy, for his intellectual contributions.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
Report on the Global AIDS Epidemic: 2008.
###end article-title 72
###begin article-title 73
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.
###end article-title 73
###begin article-title 74
###xml 53 58 <span type="species:ncbi:9606">human</span>
Molecular cloning and functional expression of a new human CC-chemokine receptor gene.
###end article-title 74
###begin article-title 75
Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.
###end article-title 75
###begin article-title 76
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural studies of chemokines that inhibit HIV-1 entry.
###end article-title 76
###begin article-title 77
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
###end article-title 77
###begin article-title 78
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of a major co-receptor for primary isolates of HIV-1.
###end article-title 78
###begin article-title 79
###xml 22 27 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.
###end article-title 79
###begin article-title 80
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
###end article-title 80
###begin article-title 81
###xml 83 88 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group.
###end article-title 81
###begin article-title 82
###xml 53 58 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Adverse effect of the CCR5 promoter -2459A allele on HIV-1 disease progression.
###end article-title 82
###begin article-title 83
###xml 113 148 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 169 176 <span type="species:ncbi:9606">infants</span>
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants.
###end article-title 83
###begin article-title 84
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS).
###end article-title 84
###begin article-title 85
###xml 55 60 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5delta32.
###end article-title 85
###begin article-title 86
###xml 129 164 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
###end article-title 86
###begin article-title 87
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.
###end article-title 87
###begin article-title 88
###xml 68 96 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Up-regulation of CCR5 expression in the placenta is associated with human immunodeficiency virus-1 vertical transmission.
###end article-title 88
###begin article-title 89
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.
###end article-title 89
###begin article-title 90
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Human immunodeficiency virus type 1 enters primary human brain microvascular endothelial cells by a mechanism involving cell surface proteoglycans independent of lipid rafts.
###end article-title 90
###begin article-title 91
Structure and function of heparan sulphate proteoglycans.
###end article-title 91
###begin article-title 92
###xml 40 50 <span type="species:ncbi:138953">poliovirus</span>
###xml 82 92 <span type="species:ncbi:138953">poliovirus</span>
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor.
###end article-title 92
###begin article-title 93
###xml 49 71 <span type="species:ncbi:10298">herpes simplex virus 1</span>
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry.
###end article-title 93
###begin article-title 94
###xml 112 139 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
###xml 141 168 <span type="species:ncbi:10310">herpes simplex virus type 2</span>
###xml 174 192 <span type="species:ncbi:10345">pseudorabies virus</span>
A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus.
###end article-title 94
###begin article-title 95
###xml 21 24 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface.
###end article-title 95
###begin article-title 96
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Tat as a transcriptional activator and a potential therapeutic target for HIV-1.
###end article-title 96
###begin article-title 97
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.
###end article-title 97
###begin article-title 98
###xml 44 79 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 attachment: another look.
###end article-title 99
###begin article-title 100
###xml 66 71 <span type="species:ncbi:9606">human</span>
Interaction of RANTES with syndecan-1 and syndecan-4 expressed by human primary macrophages.
###end article-title 100
###begin article-title 101
Binding of the CC-chemokine RANTES to syndecan-1 and syndecan-4 expressed on HeLa cells.
###end article-title 101
###begin article-title 102
Syndecans: new kids on the signaling block.
###end article-title 102
###begin article-title 103
Transcytosis and surface presentation of IL-8 by venular endothelial cells.
###end article-title 103
###begin article-title 104
Differential binding of chemokines to glycosaminoglycan subpopulations.
###end article-title 104
###begin article-title 105
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans.
###end article-title 105
###begin article-title 106
Glycosaminoglycans mediate cell surface oligomerization of chemokines.
###end article-title 106
###begin article-title 107
CCL5-CCR5-mediated apoptosis in T cells: Requirement for glycosaminoglycan binding and CCL5 aggregation.
###end article-title 107
###begin article-title 108
Structural and functional analysis of the RANTES-glycosaminoglycans interactions.
###end article-title 108
###begin article-title 109
###xml 30 34 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity.
###end article-title 109
###begin article-title 110
Biosynthesis of heparin/heparan sulfate. The D-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides.
###end article-title 110
###begin article-title 111
###xml 75 80 <span type="species:ncbi:9606">child</span>
###xml 97 100 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi.
###end article-title 111
###begin article-title 112
###xml 14 35 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 118 123 <span type="species:ncbi:9606">women</span>
The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women.
###end article-title 112
###begin article-title 113
###xml 62 66 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration.
###end article-title 113
###begin article-title 114
###xml 131 134 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Multiplex Ligase Detection Reaction-based Genotyping Analysis of CCR2-CCR5 Polymorphism Improves Large-scale Population Studies of HIV Co-receptors.: Case Western Reserve University Rutgers University.
###end article-title 114
###begin article-title 115
###xml 30 35 <span type="species:ncbi:9606">child</span>
###xml 36 39 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CCR5 haplotypes and mother-to-child HIV transmission in Malawi.
###end article-title 115
###begin article-title 116
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 289 318 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. Potential roles for haplotype and mRNA diversity, differential haplotype-specific transcriptional activity, and altered transcription factor binding to polymorphic nucleotides in the pathogenesis of HIV-1 and simian immunodeficiency virus.
###end article-title 116
###begin article-title 117
Modern Epidemiology.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This research was supported by the Centers for Disease Control and Prevention Dissertation Award (PAR 07-231, 2008) and the NIH Virology Training Grant (T32 AI007419, 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

